Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease
- PMID: 18314967
- DOI: 10.1021/ac702350g
Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease
Abstract
The quality of tissue imaging by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) depends on the effectiveness of the matrix deposition, especially for lipids that may dissolve in the solvent used for the matrix application. This article describes the use of an oscillating capillary nebulizer (OCN) to spray small droplets of matrix aerosol onto the sample surface for improved matrix homogeneity, reduced crystal size, and controlled solvent effects. This system was then applied to the analysis of histological slices of brains from mice with homozygous disruption of the hexb gene (hexb-/-), a model of Tay-Sachs and Sandhoff disease, versus the functionally normal heterozygote (hexb+/-) by imaging MALDI-MS. This allowed profiling and localization of many different lipid species, and of particular interest, ganglioside GM2, asialo-GM2 (GA2), and sulfatides (ST). The presence of these compounds was confirmed by analysis of brain extracts using electrospray ionization in conjunction with tandem mass spectrometry (MS/MS). The major fatty acid of the ceramide backbone of both GM2 and GA2 was identified as stearic acid (18:0) versus nervonic acid (24:1) for ST by both tissue-imaging MS and ESI-MS/MS. GM2 and GA2 were highly elevated in hexb-/- and were both localized in the granular cell region of the cerebellum. ST, however, was localized mainly in myelinated fiber (white matter) region of the cerebellum as well as in the brain stem with a relatively uniform distribution and had similar relative signal intensity for both hexb+/- and hexb-/- brain. It was also observed that there were distinct localizations for numerous other lipid subclasses; hence, imaging MALDI-MS could be used for "lipidomic" studies. These results illustrate the usefulness of tissue-imaging MALDI-MS with matrix deposition by OCN for histologic comparison of lipids in tissues such as brains from this mouse model of Tay-Sachs and Sandhoff disease.
Similar articles
-
Imaging MALDI mass spectrometry of sphingolipids using an oscillating capillary nebulizer matrix application system.Methods Mol Biol. 2010;656:131-46. doi: 10.1007/978-1-60761-746-4_7. Methods Mol Biol. 2010. PMID: 20680588 Free PMC article.
-
Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?J Neurochem. 1987 Sep;49(3):834-40. doi: 10.1111/j.1471-4159.1987.tb00969.x. J Neurochem. 1987. PMID: 3612128
-
Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.Endocrinology. 1998 Jul;139(7):3280-8. doi: 10.1210/endo.139.7.6117. Endocrinology. 1998. PMID: 9645704
-
Surface analysis of lipids by mass spectrometry: more than just imaging.Prog Lipid Res. 2013 Oct;52(4):329-53. doi: 10.1016/j.plipres.2013.04.005. Epub 2013 Apr 24. Prog Lipid Res. 2013. PMID: 23623802 Review.
-
[Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].Yakugaku Zasshi. 2013;133(2):269-74. doi: 10.1248/yakushi.12-00199. Yakugaku Zasshi. 2013. PMID: 23370522 Review. Japanese.
Cited by
-
Resolving brain regions using nanostructure initiator mass spectrometry imaging of phospholipids.Integr Biol (Camb). 2012 Jun;4(6):693-9. doi: 10.1039/c2ib20043k. Epub 2012 Apr 27. Integr Biol (Camb). 2012. PMID: 22543711 Free PMC article.
-
Improved matrix coating for positive- and negative-ion-mode MALDI-TOF imaging of lipids in blood vessel tissues.Anal Bioanal Chem. 2019 Jun;411(15):3221-3227. doi: 10.1007/s00216-019-01826-x. Epub 2019 Apr 30. Anal Bioanal Chem. 2019. PMID: 31037373 Free PMC article.
-
Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.Neuropsychopharmacology. 2014 Jan;39(1):34-49. doi: 10.1038/npp.2013.215. Epub 2013 Aug 21. Neuropsychopharmacology. 2014. PMID: 23966069 Free PMC article. Review.
-
Future technology insight: mass spectrometry imaging as a tool in drug research and development.Br J Pharmacol. 2015 Jul;172(13):3266-83. doi: 10.1111/bph.13135. Epub 2015 May 5. Br J Pharmacol. 2015. PMID: 25766375 Free PMC article. Review.
-
Imaging mass spectrometry for visualization of drug and endogenous metabolite distribution: toward in situ pharmacometabolomes.J Neuroimmune Pharmacol. 2010 Mar;5(1):31-43. doi: 10.1007/s11481-009-9162-6. Epub 2009 Jun 11. J Neuroimmune Pharmacol. 2010. PMID: 19513855 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous